Barclays raises price targets on Centene to $82 and Nucor to $320
Barclays lifted its Centene target from $80 to $82 and its Nucor target from $306 to $320, according to Dow Jones Newswires citing Benzinga.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays analysts raised their price target on Centene shares from $80 to $82. The information comes from Dow Jones Newswires, which cites Benzinga's ratings tracker.
For Nucor, the bank increased its target from $306 to $320 a share. The change appeared in the same batch of analyst rating actions.
why it matters
Price target changes reflect analysts' valuation views and do not on their own set the direction of share prices. Investors often read them as a signal of how sentiment on a company's outlook is shifting.
tags
instruments
sources
- Centene Price Target Raised to $82.00/Share From $80.00 by Barclays — Dow Jones Newswires, 28 October 2026 at 15:40 UTC
- Nucor Price Target Raised to $320.00/Share From $306.00 by Barclays — Dow Jones Newswires, 28 October 2026 at 15:58 UTC
- Visa Price Target Raised to $440.00/Share From $420.00 by Barclays — Dow Jones Newswires, 28 October 2026 at 16:18 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗